Literature DB >> 29321669

Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers.

Albert Grinshpun1, Naama Halpern2,3, Roy Zvi Granit4, Ayala Hubert5, Tamar Hamburger5, Yael Laitman6,3, Einat Shacham-Shmueli2,3, Yehudit Peerless5, Eitan Friedman6,3, Tamar Peretz5.   

Abstract

Mutations in the BRCA1/2 genes were recently shown to be associated with an increased risk for colorectal cancer. We characterized the largest cohort available of BRCA1/2 mutation carriers with colorectal cancer. We analyzed 32 patients with lower gastrointestinal cancers and germline BRCA1/2 mutations from two large academic hospital registries; 91% of patients were of Ashkenazi ancestry, 78% were women, and 62.5% were carriers of BRCA1 gene mutations. A high percentage of colorectal tumors (34.5%) had a mucinous histology and were located atypically in the left colon. Two patients had anal cancer with unusual histology and an additional patient had mucinous small bowel carcinoma. Gene expression analysis showed significant correlation between the gene signatures of left mucinous colorectal cancer and basal-like breast cancer. Our results imply that Ashkenazi BRCA1/2 mutation carriers with colorectal cancer might have unique characteristics with a high rate of left-sided, mucinous histology colorectal cancer, and possibly anal carcinoma. This report suggests a phenotypic influence of defects in DNA repair genes on colorectal tumors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29321669      PMCID: PMC5839043          DOI: 10.1038/s41431-017-0067-1

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  24 in total

1.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

2.  Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

Authors:  C J van Asperen; R M Brohet; E J Meijers-Heijboer; N Hoogerbrugge; S Verhoef; H F A Vasen; M G E M Ausems; F H Menko; E B Gomez Garcia; J G M Klijn; F B L Hogervorst; J C van Houwelingen; L J van't Veer; M A Rookus; F E van Leeuwen
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

3.  Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

Authors:  Matthew B Yurgelun; Matthew H Kulke; Charles S Fuchs; Brian A Allen; Hajime Uno; Jason L Hornick; Chinedu I Ukaegbu; Lauren K Brais; Philip G McNamara; Robert J Mayer; Deborah Schrag; Jeffrey A Meyerhardt; Kimmie Ng; John Kidd; Nanda Singh; Anne-Renee Hartman; Richard J Wenstrup; Sapna Syngal
Journal:  J Clin Oncol       Date:  2017-01-30       Impact factor: 44.544

4.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.

Authors:  Chad J Creighton; Xiaoxian Li; Melissa Landis; J Michael Dixon; Veronique M Neumeister; Ashley Sjolund; David L Rimm; Helen Wong; Angel Rodriguez; Jason I Herschkowitz; Cheng Fan; Xiaomei Zhang; Xiaping He; Anne Pavlick; M Carolina Gutierrez; Lorna Renshaw; Alexey A Larionov; Dana Faratian; Susan G Hilsenbeck; Charles M Perou; Michael T Lewis; Jeffrey M Rosen; Jenny C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

Review 5.  Genetic factors and colorectal cancer in Ashkenazi Jews.

Authors:  Gershon Y Locker; Henry T Lynch
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 6.  Advances in the care of patients with mucinous colorectal cancer.

Authors:  Niek Hugen; Gina Brown; Robert Glynne-Jones; Johannes H W de Wilt; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2015-09-01       Impact factor: 66.675

7.  Association between sex hormones and colorectal cancer risk in men and women.

Authors:  Jennifer H Lin; Shumin M Zhang; Kathryn M Rexrode; Joann E Manson; Andrew T Chan; Kana Wu; Shelley S Tworoger; Susan E Hankinson; Charles Fuchs; J Michael Gaziano; Julie E Buring; Edward Giovannucci
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-28       Impact factor: 11.382

8.  Supervised risk predictor of breast cancer based on intrinsic subtypes.

Authors:  Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

9.  Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer.

Authors:  Tomas Kirchhoff; Jaya M Satagopan; Noah D Kauff; Helen Huang; Prema Kolachana; Crystal Palmer; Hannah Rapaport; Khedoudja Nafa; Nathan A Ellis; Kenneth Offit
Journal:  J Natl Cancer Inst       Date:  2004-01-07       Impact factor: 13.506

10.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

View more
  3 in total

Review 1.  AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary.

Authors:  Sonia S Kupfer; Samir Gupta; Jeffrey N Weitzel; Jewel Samadder
Journal:  Gastroenterology       Date:  2020-04-23       Impact factor: 22.682

2.  Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants.

Authors:  Maria Valeria Freire; Marie Martin; Romain Thissen; Cédric Van Marcke; Karin Segers; Edith Sépulchre; Natacha Leroi; Céline Lété; Corinne Fasquelle; Jean Radermacher; Yeter Gokburun; Joelle Collignon; Anne Sacré; Claire Josse; Leonor Palmeira; Vincent Bours
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

Review 3.  Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer.

Authors:  Fabio Catalano; Roberto Borea; Silvia Puglisi; Andrea Boutros; Annalice Gandini; Malvina Cremante; Valentino Martelli; Stefania Sciallero; Alberto Puccini
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.